Latest News & Features

Reset all filters
Article Type
Channels & Sectors

Refine Search
Illumina and Molecular Loop have filed complaints over DNA testing innovations | Illumina said one Molecular Loop patent was unenforceable due to ‘inequitable conduct’   11 June 2024
Big Pharma
Victory for Amneal Pharmaceuticals as court dismisses infringement claims | Decision orders Teva to remove patents covering its breathing drug from the FDA's Orange Book | Paves the way for Amneal's generic version.   11 June 2024
Latest addition to the firm brings medtech expertise and experience assisting digital health companies using AI and machine learning | Move comes at a time when “health care companies are thinking more like technology companies”.   6 June 2024
Big Pharma
Swiss multinational claims Trividia infringed two patents | Roche says former employees with knowledge of patents joined Sinocare subsidiary.   6 June 2024
Complaint sought judicial validation of the company's patent claims for a distributive shock treatment | Disputes the PTAB's decision deeming the invention obvious.   6 June 2024
Court seen as “exceeding expectations” | Experts urge caution, emphasising that confident and reliable court judgments are needed | High-stakes patent litigation, especially in pharmaceuticals, remains predominantly within national courts.   4 June 2024
Big Pharma
Delaware judge denies DexCom’s motion to dismiss two counter-counterclaims in complex dispute with rival Abbott over glucose monitors | But judge also says Abbott is not entitled to further remedy.   4 June 2024
ABG IP says the promotions recognise staff performance, improve gender equality and lower the average age among partners, and secure its values and position in the market.   4 June 2024
University of British Columbia alleges patent infringement by medtech companies | Suit concerns AI-driven ultrasound systems for cardiac imaging.   30 May 2024
International Health Brands takes aim at former COO alleging trade secret theft of ingredients in immunity gummies | Accusations include deceptive marketing strategies, infringement, unfair competition, and misappropriation of trade secrets.   30 May 2024